Sirolimus treatment of left ventricular hypertrophy: who, and when?
Author:
Publisher
Oxford University Press (OUP)
Subject
Cardiology and Cardiovascular Medicine
Link
http://academic.oup.com/eurheartj/article-pdf/29/22/2703/1210389/ehn470.pdf
Reference21 articles.
1. mTOR Pathway as a Target in Tissue Hypertrophy
2. Is There a Role for Proliferation Signal/mTOR Inhibitors in the Prevention and Treatment of De Novo Malignancies After Heart Transplantation? Lessons Learned From Renal Transplantation and Oncology
3. Replacement of Calcineurin-Inhibitors With Sirolimus as Primary Immunosuppression in Stable Cardiac Transplant Recipients
4. January 7/14, 2003
5. Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emerging Role of mTOR Signaling-Related miRNAs in Cardiovascular Diseases;Oxidative Medicine and Cellular Longevity;2018-08-23
2. Autophagy modulation: a potential therapeutic approach in cardiac hypertrophy;American Journal of Physiology-Heart and Circulatory Physiology;2017-08-01
3. Smooth muscle protein-22-mediated deletion of Tsc1 results in cardiac hypertrophy that is mTORC1-mediated and reversed by rapamycin;Human Molecular Genetics;2011-01-06
4. Left ventricular hypertrophy in renal disease: beyond preload and afterload;Kidney International;2009-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3